Cancer Research UK and AstraZeneca have announced that they are opening a new centre in the UK, dedicated to realising the full potential of functional genomics in the discovery and development of new drugs for patients with cancer.
EUCAST has evaluated the quality of 16 antimicrobial susceptibility test (AST) discs from nine manufacturers against EUCAST targets and ranges for relevant quality control strains.
